Angstrom
Provider of high-frequency COVID-19 and respiratory pathogen testing platform
📍 Austin, United States · Infectious Diseases
Funding snapshot
Last roundSeries A
Amount$3M
Date16 June 2021
About
Provider of high-frequency COVID-19 and respiratory pathogen testing platform. The company has AMPD nanopore sequencing and a machine learning-powered platform. It is used for the diagnostics of covid-19, influenza, and respiratory pathogens.
Latest news
No articles yet.
Similar startups
NovaHealth AI
Clinical documentation copilot for ambulatory care networks in the US.
Statiq
Manufacturer of electric vehicle charging hardware and operator of networks
Spyne.ai
Platform offering AI-powered imaging for vehicle photography
Immuneel
Developer of T-cell therapies for the treatment of cancer